Andrew Galler
Stock Analyst at Morgan Stanley
(0.58)
# 4,064
Out of 5,008 analysts
29
Total ratings
33.33%
Success rate
-14.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Equal-Weight | $35 | $34.22 | +2.28% | 13 | Mar 7, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $8.16 | +83.82% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $5.14 | +250.19% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $36.54 | +1.26% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $68.94 | -18.77% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $5.66 | +218.02% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $63.91 | -15.50% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $66.02 | -24.27% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $4.31 | +920.88% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $27.34 | +1,011.92% | 1 | Nov 9, 2021 |
Immunocore Holdings
Mar 7, 2025
Assumes: Equal-Weight
Price Target: $35
Current: $34.22
Upside: +2.28%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $8.16
Upside: +83.82%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $5.14
Upside: +250.19%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $36.54
Upside: +1.26%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $68.94
Upside: -18.77%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $5.66
Upside: +218.02%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $63.91
Upside: -15.50%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $66.02
Upside: -24.27%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $4.31
Upside: +920.88%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $27.34
Upside: +1,011.92%